Ken Staley is a senior associate with the Global Health Policy Center at the Center for Strategic and International Studies. Previously, he was the leader of the U.S. President’s Malaria Initiative (PMI), the largest bilateral effort in history to eradicate malaria. At PMI, he created advanced data and analytics capabilities that integrate climate, epidemiological, financial, and operations data. During the Covid-19 pandemic he was the executive director for USAID’s COVID-19 Task Force, where he was responsible for safety, security, continuity of operations, and response and led USAID’s planning for distribution of the Covid-19 vaccine. Prior to his appointment as malaria coordinator, Dr. Staley was a consultant at McKinsey & Company, where he advised private sector clients and assisted public health responses to Ebola and MERS. Earlier, he served as a strategy adviser to Kinsa, a health data company. He began his career in the private sector at Medtronic, where he led new ventures in China and India focused on expanding patient access through business model innovation. Before entering the private sector, Dr. Staley was the deputy assistant secretary of state for counterproliferation (acting) and director for biodefense policy at the White House Homeland Security Council, where he helped to design and then lead implementation of the National Strategy for Pandemic Influenza. He received his MD from the University of Iowa Carver College of Medicine and MPA from the Harvard Kennedy School and is an honors graduate of Washington University in Saint Louis.